List View Detail View 601-625 of 761 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 24 25 26 ... 31 Next Product Clone Appl. Reg Cat# Size Brilliant Violet 750™ anti-human CD273 (B7-DC, PD-L2) Antibody MIH18 FC RUO 345527 25 tests ¥45,980 345528 100 tests ¥93,280 Brilliant Violet 785™ anti-human CD273 (B7-DC, PD-L2) Antibody MIH18 FC RUO 345531 25 tests ¥46,200 345532 100 tests ¥101,200 Brilliant Violet 711™ anti-human CD273 (B7-DC, PD-L2) Antibody MIH18 FC RUO 345533 25 tests ¥50,600 345534 100 tests ¥100,100 Brilliant Violet 421™ anti-human CD273 (B7-DC, PD-L2) Antibody MIH18 FC RUO 345520 100 tests ¥82,720 Brilliant Violet 650™ anti-human CD273 (B7-DC, PD-L2) Antibody MIH18 FC RUO 345530 100 tests ¥89,100 FITC anti-human CD274 (B7-H1, PD-L1) Antibody MIH2 FC RUO 393605 25 tests ¥31,020 393606 100 tests ¥67,100 APC anti-human CD274 (B7-H1, PD-L1) Antibody MIH2 FC RUO 393609 25 tests ¥36,520 393610 100 tests ¥78,100 PE anti-human CD274 (B7-H1, PD-L1) Antibody MIH2 FC RUO 393607 25 tests ¥33,660 393608 100 tests ¥71,060 Purified anti-human CD274 (B7-H1, PD-L1) Antibody MIH2 FC RUO 393602 100 µg ¥24,640 Spark NIR™ 685 anti-human CD274 (B7-H1, PD-L1) (Flexi-Fluor™) Antibody MIH2 FC RUO 285598 50 µg ¥86,680 Ultra-LEAF™ Purified anti-human CD274 (B7-H1, PD-L1) Antibody MIH2 FC RUO 393603 100 µg ¥41,170 393604 1 mg ¥123,340 Spark YG™ 581 anti-human CD274 (B7-H1, PD-L1) (Flexi-Fluor™) Antibody MIH2 FC RUO 285533 50 µg ¥86,680 Spark YG™ 593 anti-human CD274 (B7-H1, PD-L1) (Flexi-Fluor™) Antibody MIH2 FC RUO 285564 50 µg ¥86,680 FITC anti-human CD272 (BTLA) Antibody MIH26 FC RUO 344523 25 tests ¥29,920 344524 100 tests ¥81,400 APC anti-human CD272 (BTLA) Antibody MIH26 FC RUO 344509 25 tests ¥33,880 APC/Cyanine7 anti-human CD272 (BTLA) Antibody MIH26 FC RUO 344517 25 tests ¥36,300 Alexa Fluor® 647 anti-human CD272 (BTLA) Antibody MIH26 FC RUO 344520 100 tests ¥82,500 See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 ... 24 25 26 ... 31 Next
Follow Us